Literature DB >> 6264383

Adrenalectomy and chemical sympathectomy by 6-hydroxydopamine. Effects on basal and stimulated insulin secretion.

B Ahrén, I Lundquist.   

Abstract

Influences of the sympatho-adrenal system on basal and stimulated insulin secretion were studied in vivo in the conscious mouse and rat. In the mouse, adrenalectomy or chemical sympathectomy, induced by 6-hydroxydopamine, lowered basal insulin concentrations moderately. A marked depression of basal insulin concentration (about 50%) was seen after the combined treatment of chemical sympathectomy and adrenalectomy. In short-term experiments in mice, insulin secretion stimulated by glucose or the cholinergic agonist carbachol was enhanced after chemical sympathectomy and/or adrenalectomy, whereas insulin release induced by the synthetic octapeptide of cholecystokinin (CCK-8) was inhibited. The promoting influences on the insulin secretory response to carbachol displayed a rapid development whereas those to glucose developed more slowly. In contrast, the inhibiting effect on CCK-8 stimulated insulin release vanished with time. The insulin secretory response to the beta 2-adrenoceptor stimulator, terbutaline, was increased after chemical sympathectomy, unaffected by adrenalectomy, and decreased after chemical sympathectomy plus adrenalectomy. The glucose elimination rate after 6 weeks of chemical sympathectomy was increased in mice and decreased in rats. The insulin secretory response to glucose was enhanced in mice, whereas it tended to diminish in rats after long-term sympathectomy. In conclusion, the sympatho-adrenal system is involved in regulation of basal insulin concentrations in the mouse, and apparently is of great importance for stimulated insulin secretion; the influence being dependent on the nature of the secretagogue.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6264383     DOI: 10.1007/bf00582705

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  23 in total

1.  The release of pancreatic glucagon and inhibition of insulin in response to stimulation of the sympathetic innervation.

Authors:  S R Bloom; A V Edwards
Journal:  J Physiol       Date:  1975-12       Impact factor: 5.182

2.  Interaction of amines and aminergic blocking agents with blood glucose regulation. II. Alpha-adrenergic blockade.

Authors:  I Lundquist
Journal:  Eur J Pharmacol       Date:  1972-05       Impact factor: 4.432

3.  Insulin secretion in adrenergic insufficiency in man.

Authors:  R G Brodows; F X Pi-Sunyer; R G Campbell
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

4.  The occurrence of biogenic monoamines in the mammalian endocrine pancreas.

Authors:  L Cegrell
Journal:  Acta Physiol Scand Suppl       Date:  1968

5.  The role of the adrenergic innervation to the pancreatic islets in the control of insulin release during exercise in man.

Authors:  J Järhult; J Holst
Journal:  Pflugers Arch       Date:  1979-12       Impact factor: 3.657

6.  Blood glucose level in mice. 1. Evaluation of a new technique of multiple serial sampling.

Authors:  C Rerup; I Lundquist
Journal:  Acta Endocrinol (Copenh)       Date:  1966-07

7.  Neural regulation of insulin secretion in the dog.

Authors:  D Porte; L Girardier; J Seydoux; Y Kanazawa; J Posternak
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

8.  Inhibition of insulin release by norepinephrine in man.

Authors:  D Porte; R H Williams
Journal:  Science       Date:  1966-05-27       Impact factor: 47.728

9.  Reflex adrenergic control of endocrine pancreas evoked by unloading of carotid baroreceptors in cats.

Authors:  J Järhult; J J Holst
Journal:  Acta Physiol Scand       Date:  1978-10

10.  beta-Adrenergic insulin release and adrenergic innervation of mouse pancreatic islets.

Authors:  I Lundquist; L E Ericson
Journal:  Cell Tissue Res       Date:  1978-10-06       Impact factor: 5.249

View more
  1 in total

1.  Pharmacodynamics of glucose regulation by methylprednisolone. II. normal rats.

Authors:  Jin Y Jin; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2009-01       Impact factor: 1.627

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.